トリフルリジンとティピラシル誘発のDPD阻害がDPD欠乏症を模倣する:症例報告
Antonin Schmitt1, Baptiste Bouillet2, Bernard Royer3,4
1Université Bourgogne Europe, Centre Georges-François Leclerc, Service Pharmacie, INSERM, CTM UMR 1231, TIRECS, Dijon, France.
Frontiers in oncology
|August 28, 2025
まとめ
トリフルリジン/ チピラシルの治療はウラシルの誤った値上昇を引き起こし,転移性大腸がん (mCRC) の患者における二酸化ピリミジン脱水素酶 (DPD) 検査に影響を与える可能性があります. DPDのフェノタイプ化は,トリフルリジン/ティピラシル治療の際に慎重にタイミングを決め,正確な結果が得られるようにする必要があります.
科学分野:
- 腫瘍学
- 薬理学について
- 臨床化学
背景:
- 5- フローロウラシル (5- FU) のようなフローロピリミジンは,転移性大腸がん (mCRC) の標準である.
- トリフルリジン/ティピラシル (TAS-102) は,潜在的第一線治療を含む,mCRCに対してますます使用されている経口薬である.
- ディヒドロピリミジンデヒドロゲネーゼ (DPD) の活性に関する正確な評価は,フッ素ピリミディンの安全な投与に不可欠です.
関連する概念動画
Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376
Drugs for Treatment of Diarrhea-Predominant IBS
292
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
292


